5 studies found for:    Gastrin-releasing peptide receptor
Show Display Options
Rank Status Study
1 Recruiting 68Ga-RM2 for PET/CT of Gastrin Releasing Peptide Receptor (GRPr) Expression in Prostate Cancer
Condition: Prostate Cancer
Interventions: Radiation: 68Ga-RM2 (RM2);   Device: PET/CT Scan
2 Recruiting 68Ga-NOTA-Aca-BBN(7-14) PET/CT in Patients With Primary Gliomas
Condition: Glioma
Interventions: Drug: 68Ga-NOTA-Aca-BBN;   Device: PET/CT
3 Recruiting 68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer
Condition: Prostate Adenocarcinoma
Interventions: Radiation: Gallium Ga 68-labeled GRPR Antagonist BAY86-7548;   Procedure: Magnetic Resonance Imaging;   Procedure: Positron Emission Tomography
4 Active, not recruiting 68Ga-DOTA-Bombesin PET/MRI in Imaging Patients With Prostate Cancer
Condition: Prostate Carcinoma
Interventions: Radiation: Gallium Ga 68-labeled GRPR Antagonist BAY86-7548;   Procedure: Magnetic Resonance Imaging;   Procedure: Positron Emission Tomography
5 Recruiting Detection of Genetic Markers of Lung Cancer
Condition: Non-small Cell Lung Cancer
Interventions: Procedure: Biopsy of the major carinal area;   Procedure: Biopsy of abnormal & suspicious areas of the bronchial tree;   Procedure: Evaluation of the tumor for DNA mutations;   Procedure: Bronchoalveolar Lavage (BAL) for cytokine analysis;   Procedure: Correlation of flow cytometric & RT PCR for TNM stage;   Procedure: Analysis of lymph nodes

Indicates status has not been verified in more than two years